Antitubercular and antibacterial activity of quinonoid natural products against multi-drug resistant clinical isolates

Phytotherapy Research

Volumn 28, Issue 7, 2014, Pages 1014-1021

  Dey, Diganta ^a,b   Ray, Ratnamala ^b   Hazra, Banasri ^a  

^a JADAVPUR UNIVERSITY   (India)

^b Department of Microbiology   (India)

Author keywords

clinical isolates; multi drug resistance; Mycobacterium tuberculosis; natural products; quinonoids

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CYCLOSERINE; DIOSPYRIN; EMODIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; MENADIONE; PLUMBAGIN; PYRAZINAMIDE; QUINONE DERIVATIVE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; SULTAMICILLIN; THYMOQUINONE; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTITUBERCULAR ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SCREENING; DRUG STRUCTURE; ESCHERICHIA COLI; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; KLEBSIELLA; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS; POSIBACTERIA;

CLINICAL ISOLATES; MULTI-DRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NATURAL PRODUCTS; QUINONOIDS;

ANTITUBERCULAR AGENTS; DIOSPYROS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; PLANT EXTRACTS; PLUMBAGINACEAE; QUINONES; RHAMNACEAE;

EID: 84904256753     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5090     Document Type: Article

References (33)

1. Adeniyi BA, Fong HH, Pezzuto JM, Luyengi L, Odelola HA,. 2000. Antibacterial activity of diospyrin, isodiospyrin and bisisodiospyrin from the root of Diospyros piscatoria (Gurke) (Ebenaceae). Phytother Res 14: 112-117. (Pubitemid 30168561)
2. Basu S, Ghosh A, Hazra B,. 2005. Evaluation of the antibacterial activity of Ventilago madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn.: isolation of emodin and physcion as active antibacterial agents. Phytother Res 19: 888-894. (Pubitemid 41665959)
3. Caviedes L, Delgado J, Gilman RH,. 2002. Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 40: 1873-1874. (Pubitemid 34493180)
4. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement (Document M100-S23). CLSI: Wayne, PA.
5. Collee JG, Fraser AG, Marmion BP, Simmons A,. 1996. Mackie and McCartney Practical Medical Microbiology, 14th edn. Churchill Livingstone: London.
6. Cowan MM,. Plant products as antimicrobial agents. 1999. Clin Microbiol Rev 12: 564-582. (Pubitemid 29484747)
7. Dey D, Debnath S, Hazra S, Ghosh S, Ray R, Hazra B,. 2012. Pomegranate pericarp extract enhances the antibacterial activity of ciprofloxacin against extended-spectrum β-lactamase [ESBL] and metallo-β-lactamase [MBL] producing Gram-negative bacilli. Food Chem Toxicol 50: 4302-4309.
8. Guzman JD, Gupta A, Bucar F, Gibbons S, Bhakta S,. 2012. Antimycobacterials from natural sources: ancient times, antibiotic era and novel scaffolds. Front Biosci (Landmark Ed) 17: 1861-1881.
9. Hazra B, Das Sarma M, Sanyal U,. 2004. Separation methods of quinonoid constituents of plants used in Oriental traditional medicines. J Chromatogr B Analyt Technol Biomed Life Sci 812: 259-275. (Pubitemid 39535416)
10. Hazra B, Sarkar R, Bhattacharyya S, Ghosh PK, Chel G, Dinda B,. 2002. Synthesis of plumbagin derivatives and their inhibitory activities against Ehrlich ascites carcinoma in vivo and Leishmania donovani promastigotes in vitro. Phytother Res 16: 133-137. (Pubitemid 34297455)
11. Hur M, Moon H-W, Yun Y-M, et al,. 2011. Detection of tuberculosis using artus® M. tuberculosis PCR kit and COBAS® AMPLICORTM Mycobacterium tuberculosis test. Int J Tuberc Lung Dis 15: 795-798.
12. Kanokmedhakul K, Kanokmedhakul S, Phatchana R,. 2005. Biological activity of Anthraquinones and Triterpenoids from Prismatomeris fragrans. J Ethnopharmacol 100: 284-288. (Pubitemid 41206622)
13. Karkare S, Chung TT, Collin F, et al,. 2013. The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action. J Biol Chem 288: 5149-5156.
14. Kouidhi B, Zmantar T, Jrah H, et al,. 2011. Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens. Ann Clin Microbiol Antimicrob 10: 29.
15. Kumarasamy KK, Toleman MA, Walsh TR, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.
16. Lajubutu BA, Pinney RJ, Roberts MF, Odelola HA, Osog BA,. 1995. Antibacterial activity of diosquinone and plumbagin from the root of Diospyros rnespiliformis (Hostch) (Ebenaceae). Phytother Res 9: 346-350.
17. Lall N, Hazra B, Das Sarma M, Meyer JJM,. 2003. In vitro activity of derivatives of diospyrin against drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis. J Antimicrob Chemother 51: 435-438. (Pubitemid 36231172)
18. Mallavadhani UV, Panda AK, Rao YR,. 1998. Pharmacology and chemotaxonomy of Diospyros. Phytochemistry 49: 901-951. (Pubitemid 28457627)
19. Mathew R, Kruthiventi AK, Prasad JV, Kumar SP, Srinu G, Chatterji D,. 2010. Inhibition of Mycobacterial Growth by Plumbagin Derivatives. Chem Biol Drug Des 76: 34-42.
20. Mossa JS, El-Feraly FS, Muhammad I,. 2004. Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide. Phytother Res 18: 934-937. (Pubitemid 40052774)
21. Mukanganyama S, Chirisa E, Hazra B,. 2012. Antimycobacterial activity of diospyrin and its derivatives against Mycobacterium aurum. Res Pharm 2: 01-13.
22. Newton SM, Lau C, Wright CW,. 2000. A review of antimycobacterial natural products. Phytother Res 14: 303-322. (Pubitemid 30655514)
23. Nohl H, Jordan W, Youngman RJ,. 1986. Quinones in biology: functions in electron transfer and oxygen activation. Adv Free Radic Biol Med 2: 211-279. (Pubitemid 16010533)
24. Pullen C, Schmitz P, Meurer K, et al,. 2002. New and bioactive compounds from Streptomyces strains residing in the wood of Celastraceae. Planta 216: 162-167. (Pubitemid 36761560)
25. Salem ML,. 2005. Immunomodulatory and therapeutic properties of Nigella sativa L seed. Int Immunopharmacol 5: 1749-1770. (Pubitemid 41594584)
26. Smolarz HD, Swatko-Ossor M, Ginalska G, Medyńska E,. 2013. Antimycobacterial effect of extract and its components from Rheum rhaponticum. J AOAC Int 96: 155-160.
27. Thorpe TC, Wilson ML, Turner JE, et al. 1990. BacT/Alert: an automated colorimetric microbial detection system. J Clin Micro 28: 1608-1612. (Pubitemid 20212894)
28. Tran T, Saheba E, Arcerio AV, et al,. 2004. Quinones as antimycobacterial agents. Bioorg Med Chem 12: 4809-4813. (Pubitemid 39164388)
29. van Ingen J, van der Laan T, Dekhuijzen R, Boeree M, van Soolingen D,. 2010. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in the Netherlands. Int J Antimicrob Agents 35: 169-173.
30. World Health Organization. 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB): global report on surveillance and response (WHO/HTM/TB/2010.3.). WHO: Geneva, Switzerland. (URL: http://whqlibdoc.who.int/publications/2010/ 9789241599191-eng.pdf)
31. World Health Organization. 2011. World health statistics 2011. WHO: Geneva, Switzerland. (URL: http://www.who.int/whosis/whostat/EN-WHS2011-Full. pdf)
32. World Health Organization. 2012. Global tuberculosis report (WHO/HTM/TB/2012.6.). WHO: Geneva, Switzerland. (URL: http://www.who.int/tb/ publications/global-report/gtbr12-main.pdf)
33. Zumla A, Grange J,. 1998. Tuberculosis. BMJ 316: 1962-1964.